ANNOUNCEMENTS

SEPT. 17 CYCLOTRON TOURS

On Saturday, Sept. 17, from 9:00 am to 1:00 pm, the public is invited to an open house and tour of the cyclotron in observance of Mens Health Day. Bring your family and friends to tour the ProCure Proton Therapy Center in Oklahoma City, or to the CDH Proton Center, A ProCure Center in Warrenville, IL. The OKC event is being hosted in conjunction with INTEGRIS Cancer Institute of Oklahoma around activities such as free prostate screenings and a live broadcast of the Sports Animal.

SUMMER 2011
Welcome to the first issue of the ProCure Proton Therapy Centers newsletter. Wed like to keep you up-to-date on center news and share some of our patient stories. We hope to publish the newsletter quarterly and encourage you to submit ideas, your stories and photos and feedback. Please send any ideas or suggestions to Marcia Shields at marcia.shields@okc.procure.com.

SIGN UP FOR BOB

CHICAGO CENTER CELEBRATES 100 PATIENTS TREATED

South suburban mans graduation marks milestone for Illinois first proton therapy center
The CDH Proton Center, A ProCure Center, celebrated a major milestone July 14, as its 100th patient completed treatment for cancer at the states first proton therapy center. The patient, James Tonkin, 63, of Plainfield, Ill., was joined by many of the Centers patients, friends and family members during a graduation ceremony with representatives from Central DuPage Hospital (CDH), Radiation Oncology Consultants and ProCure Treatment Centers. We have been very encouraged by the positive results our patients continue to see, said William Hartsell, M.D., medical director of the CDH Proton Center, A ProCure Center. Although a majority of our patients have come from nearby cities and states, we have been very fortunate to be able to offer the power of proton therapy to patients from 12 states across the country and overseas.

Brotherhood of the Balloon, known as BOB or Proton Bob, is an organization founded by Bob Marckini, a prostate patient treated with proton therapy at Loma Linda 11 years ago. Bob created the organization as a way to keep the fellowship going with the good friends he made during treatment. Today, the BOB organization has grown to more than 5,300 members from all over the world who have been treated with proton therapy. Approximately 500 patients per year at Loma Linda have been referred by BOB members. The voice of proton therapy treatment for prostate cancer, BOB supports its members with the latest news and research on proton therapy, cancer recurrence prevention, insurance coverage, diet and lifestyle tips, member reunions, member stories and feedback after five, 10, 20 years following treatment, participation in surveys and access to results and much more. Get connected to this important organization and share your own stories and statistics. According to the American Cancer Society, Research has shown that being part of a support group following cancer treatment improves quality of life, and enhances patient survival. Please visit www.protonbob.com.

SPEAK FOR PROTONS

Many of our patients are eager to help spread the word about proton therapy, and how it has had such a positive effect on their health and quality of life. Some patients elect to speak on their own at church and civic functions, and many ask us to participate with them for the presentations. If you would like to speak and/or have a ProCure representative speak with you, please contact Marcia Shields in Oklahoma City (marcia.shields@okc.procure.com, 405773-6740) or Beverly Tanabe in Chicago (beverly. tanabe@chi.procure.com, 630-821-6403).

PROCURE CANCER FOUNDATION

ProCure CEO Hadley Ford, Chicago ProCures 100th patient James Tonkin & Chicago ProCure President Jim Williams

Since opening on October 19, 2010, the Center has used proton therapy to treat patients with noncancerous tumors and cancerous tumors in the brain, central nervous system, head and neck, lung, gastrointestinal tract and prostate, as well as sarcomas and many pediatric cancers.

The ProCure Cancer Foundation provides support to proton radiation therapy patients in need of financial assistance by funding non-medical expenses associated with the treatment to ensure access to the improved quality of life proton therapy enables. The foundation also supports patients at ProCure Proton Therapy Centers and in non-ProCure proton treatment centers. For more information, to apply for a grant, or to donate, please visit http://www.procurecancerfoundation.org.

JUSTINS STORY: TREATMENT FOR CANCER AND SPIRIT

Before Justin Rodriguez was diagnosed with cancer last October, his mother, Yasmin, considered him her rock. Raising two other children with mental disorders, one diagnosed with Aspergers syndrome and the other diagnosed with ADHD, sixyear-old Justin had always been the calming force in her life. Justin was always my perfectly healthy little boy, said Yasmin. When he got sick it just turned our world upside down. Last fall Justin began having mood swings and suffering from migraines and chronic fatigue. Doctors in Lawton, Okla. originally diagnosed him with exhaustion, but Yasmin insisted it was something else causing her sons illness. On October 17, 2010 Justin was taken to the Childrens Hospital at OU Medical Center in Oklahoma City where they found a Justin Rodriguez & Nurse Pam Cannon lemon-sized tumor in the middle of his brain. Five days later he was diagnosed with having a malignant germ cell tumor causing spinal fluid build-up and pressure on his brain. Justin immediately began a chemotherapy regimen, but after five rounds, his doctors decided it was ineffective. The tumor had now grown to the size of a baseball and needed to be removed immediately. More chemotherapy followed before Justin was sent to ProCure Proton Therapy Center in Oklahoma City for treatment. The Rodriguez family received a grant from the ProCure Cancer Foundation, which provides support to proton radiation therapy patients in need of financial assistance. The grants fund non-medical expenses associated with treatment to ensure patients have access to the improved quality of life proton therapy enables. For Yasmin, the grant meant more funds available to house, feed and care for her husband and three children. At the center, Justin and Yasmin found more than just treatment for his cancer. According to Yasmin, they found treatment for their spirit as well. The staff and other patients foster an environment where Justin could be Justin, said Yasmin. He went from looking and acting like a sick boy, to the Justin I remembered before his diagnosis.

PROCURE HAS THE MAJORITY OF U.S. PROTON CERTIFIED THERAPISTS

ProCures Training and Development Center (TDC) in Bloomington, Ind. is the only training facility in the world dedicated to proton therapy. The TDC provides courseware to Ivy Tech Community CollegeBloomington, which provides accreditation and is the nations first and only proton therapy certification program, operating as part of the colleges Radiation Therapy Program. This month ProCure and Ivy Tech will graduate 12 additional therapists from ProCures Chicago center and six from OKC, bringing the total number of graduates certified in proton therapy to 65. Of those 65, 57 therapists are employed by ProCure. There are currently about 300 therapists working in proton therapy, out of approximately 30,000 registered radiation therapists. Beginning in 2012, the proton certification program will be offered publicly to any licensed radiation therapist. For more information please visit www.ivytech.edu.

ProCure Proton Therapy Center

HELP OTHERS AND SHARE YOUR STORY

TESTIMONIALS TO BE FILMED IN OKC
Remember when you first got your diagnosis? You were probably frightened, confused, and wanted all the information you could possibly find. Weve heard patients say the best source of information is that from former patients who had the same questions and fears, did their research and are willing to discuss their journey. Every day there are hundreds of newly diagnosed cancer patients needing to hear your stories of survival, support and encouragement. You can help. On August 17 and 24, directly following the graduation luncheon at the ProCure Proton Therapy Center in Oklahoma City, we will be filming patient testimonials in a conference room. We encourage you to tell your story. These short film clips will be posted on our Website and available for those who need to hear from you. We will of course ask you to sign a release for permission to use your story. If you are interested please call 405-773-6740 or email marcia.shields@ okc.procure.com and well schedule your testimony. Please be sure to join us for lunch that day, or at any of our Wednesday graduation luncheons. View other patient stories at http://www.procure.com/PatientStories.aspx.

RIP VANWINKLE, 92, DIDNT ACCEPT LIVE IT OUT

At 92 years old, Rip VanWinkle was diagnosed with prostate cancer. Because of his age, his primary physician and urologist told him he was lucky to have led such a long life. They suggested he forgo treatment and happily live out the remainder of his days. This lack of treatment was not good enough for Rips wife, Elaine, who had spent 45 years as a registered nurse. Familiar with the health system and the obstacles they could face while searching for the right treatment, Rip and Elaine looked to friends recently treated for prostate cancer for guidance. This is both of our second marriages, and were just getting started, Elaine said. I need him around for a few more years, not months. Rip and Elaine first sat down with two couples, of which the husbands had recently gone through treatment for prostate cancer. One had chosen hormone therapy while the other chose traditional radiation therapy, and both couples were unhappy with the result. Both of these gentlemen suffered serious side effects after treatment and were unable to return to the lifestyles they led before being diagnosed. When they spoke to a third friend who was receiving proton therapy, Rip and Elaine were relieved to hear about a treatment that didnt seem to affect their friends quality of life. Upon further research, Rip and Elaine decided proton therapy was the best cancer treatment option for them to maintain their active lifestyle. With only seven proton therapy centers in the United Sates, Rip was referred to ProCure Proton Therapy Center in Oklahoma City where he began treatment for his prostate cancer in February 2010. During their time at the treatment center, Rip and Elaine made a lasting impression with everyone who had the chance to meet them, and generously spread the word about proton therapy to anyone who would listen. Between dancing twice a week with the OKC Swing Dance club, knitting scarves for every staff member at the center and religiously attending patient luncheons and dine-arounds, Rip somehow managed to squeeze his treatments into his daily routine. We think everyone we meet needs to know about the ProCure Proton Therapy Center, and deserves the opportunity to come here, if they need it, he said. ProCure Proton Therapy Center 3
Rip VanWinkle

UK PATIENTS HOP THE POND FOR PROTONS

The first pediatric patients from the United Kingdom have recently completed their treatment at the ProCure Proton Therapy Center in Oklahoma City. Leah Lilly Gillon, 22 months old from Birmingham, England, and Thomas Adams, 24 months old from Liverpool, England, came to ProCure Proton Therapy Center in Oklahoma City. Their physicians in the UK had determined traditional radiation was not an option for either of them due to their young age. Because traditional radiation was not an option for either Lilly or Thomas, the National Health Service (NHS) in the UK deemed each of them as candidates for proton therapy. Both Lilly and Thomas were at the Oklahoma center receiving proton therapy treatment within three to four months after their diagnosis.

LILLY GILLON

Lilly was originally diagnosed in February with a fourth ventricle tumor. Following surgery and a short stint of chemotherapy, Lilly and her family were on their way to Oklahoma City. Lilly was initially accompanied by her mother, Cheria, and her Aunt Brenda while father, Graham, stayed in England with Lillys three older sisters. When he joined them after the first half of her treatment schedule, Graham could not believe the transformation Lilly had taken in such a short time. After Lilly had her tumor removed in February, she stopped eating, stopped speaking and stopped walking. When I arrived in Oklahoma City I was delighted to see how happy and healthy she was, said Graham. She was walking and was definitely enjoying American food, especially fries and ranch sauce. Lilly is now the happy child she was before she was diagnosed with cancer, added Graham. When we return home, Ill be talking to anyone who will listen, including the NHS review board, about how brilliant this experience and these people have been at the treatment center in Oklahoma City.
Lilly Gillon

THOMAS ADAMS

Thomas was diagnosed in January of 2011 with a rare brain tumor. His parents, Ted and Rebecca, are both physicians and were dedicated to making sure he received the best and most advanced treatment available. After two operations and three months of ineffective chemotherapy, the Adams were granted funding from the NHS for Thomas to receive proton therapy at ProCure Proton Therapy Center in Oklahoma City. Although we are both physicians, we didnt entirely understand proton therapy, said Ted. But if it could help cure our son, we were determined to make sure he received the most effective treatment possible. Thomas arrived at the OKC center in June with his parents and a soon-to-be little brother. Rebecca was eight months pregnant when they arrived, making the situation that much more difficult. Thomas and his parents welcomed his little brother, Inan, into the world in late June, and according to Thomas father, they would return to the UK with three incredible gifts. We left for home with a boy who is (hopefully) cured, a little baby and some great new friends, said Ted. The American spirit of hospitality and all around greatness has been evident in Oklahoma and at the ProCure Proton Therapy Center. He added, Not many people will come to the United States and go back with their own personal souvenir, but weve got one and his name is Inan.

Ted, Rebecca & Thomas Adams

ProCure Proton Therapy Center

FROM OUR PATIENTS

Our patients say thanks for making the experience as positive and pleasant as possible.
This poem was written and recited by Gordon Thornhill at his graduation ceremony at ProCure Proton Therapy Center in OKC.

PROTON BEAM MY FAVORITE THINGS

By Gordon Thornhill When the bell rings When my pee stings When Im feeling sad I simply remember my favorite things And then I dont feel so bad

View Radiation Vacation, produced by OKC ProCure graduates Gary Bridwell (Edmond, Okla.) and Derek Rose (Las Vegas, Nev.): View Here

Smiling faces about with the warmest of greetings At the front desk and at all of the meetings They make me feel welcome and just like a king These are a few of my favorite things! When my gown flaps Then my team claps And Im feeling sad I simply remember my favorite things And then I dont feel so bad Nurse Rachel with questions from A to Z How are feeling, do you have ED? Water, more water til I could make springs There are a few of my favorite things Merediths smile as she says Now be still Lie on the table and dont be a pill Lindsey is dancing as if she has wings These are a few of my favorite things. When insurance says no! Then Peggy re-loads And says Dont feel so sad, Just remember your favorite things And I will go after the cads! Does this help your golf game? asks Matt and John With bubbly Jordan and Zanes steady brawn Doctor Keoles examining These are a few of my favorite things Now my cure comes! I must leave soon And Im feeling sad But I will remember my favorite folks And then I wont feel soooo bad!

Share Chicago graduate Martin Rhombergs journey as he documents his experience and education through proton therapy: View Here

INKED FOR PROTONS Former OKC ProCure patient Pete Heggs from Laramie, Wyo. shows off his tattoo of the Bragg Peak, captured in an Indian dreamcatcher with a hydrogen atom in the middle. Omar Zeidan, P.h.D., director of medical physics in OKC, provided consultation for the design.

ProCure Proton Therapy Center

EXTRA EFFORT TO GET PROTON COVERAGE WILL YIELD LIFETIME OF BENEFITS

No area of our lives is as complex or mysterious as health insurance. Do you really understand what is covered, particularly for complex diagnoses such as cancer? Have you really read your actual health insurance policy, and not just the typical 20-page plan summary? Have you read all of the related documents, none of which are easily accessible, needed to understand your health insurance policy? With private insurance, most large insurance companies cover and pay for proton therapy for many tumor sites. However, many of us have faced the frustration and extra effort required to obtain approval for coverage or have been denied coverage when approval was initially sought. The ProCure financial counselors work directly with patients and are supported by experts within the company and across the country. There are two major challenges for proton therapy with respect to insurance. The first challenge is that insurance companies do not like to pay for expensive services. The insurance companies deal with cancer patients who, and rightfully so, have a greater sense of urgency for treatment than most other types of patients. Cancer patients often are receiving conflicting advice from friends, family and, too often, physicians. Unfortunately, because approval for less expensive alternatives to proton therapy can be much quicker than for proton therapy, many patients give up and accept what is easiest. The second challenge is that, understandably, insurance companies do not want to pay for ineffective care. Although proton therapy has been used as a cancer treatment since the 1950s and was approved by Medicare in 1996, it is still a rare form of treatment. Fewer than 6,000 U.S. patients were treated with proton therapy in 2010 vs. more than 900,000 treated with other forms of radiation therapy. There are many types of cancer that can be treated effectively with proton therapy. Because of the wide variety of tumor types that protons can treat, very few cases of each type are seen by most insurance companies. This results in payors inclination to confuse a rare treatment with an unproven treatment. This is especially true for cancers such as lung and breast tumors, which physicians at major academic medical centers are only recently treating with proton therapy to greatly reduce side effects and improve quality of life. We have made good strides with the insurance companies and most patients who come to us for proton therapy, once our doctors determine they are in fact proton therapy-appropriate patients, are able to attain coverage. ProCure will continue to work closely with insurance plans and patients to ensure our patients have access to and coverage for the best possible treatments. The extra effort up-front provides a lifetime of benefits.

WORLD-RENOWNED RADIATION ONCOLOGIST JOINS PROCURE

World-renowned for his expertise in proton radiotherapy, Dr. Eugen B. Hug is medical director and chief medical officer for ProCure Treatment Centers, Inc., overseeing medical operations, clinical research and treatment protocols for all of ProCures proton therapy centers in the United States. A pioneer in the use of proton therapy for pediatric tumors, Dr. Hugs influence in radiation oncology is felt worldwide. From the United States to Europe to China, he has spent more than 20 years treating patients, conducting research, teaching and writing. He is widely published in radiation oncology periodicals and books, authoring numerous journal articles or chapters. Additionally, he is a sought-after lecturer and teacher at international medical meetings, symposia, and seminars. He was principal or co-investigator of various clinical trials, including studies focusing on proton therapy. His research interests include ultra-precision radiation therapy and treatment of pediatric malignancies, connective tissue disease and skull-base and central nervous system tumors. Twice he has been named as one of the Best Doctors in America. Prior to joining ProCure, Dr. Hug served as director of the Center for Proton Therapy at the Paul Scherrer Institute in Villigen, Switzerland and as professor and chair of proton-radiotherapy at the University of Zurich. He has held various leadership roles in the past, including chief of the Section of Radiation Oncology at Dartmouth Hitchcock Medical Center, and associate director of the NCI-designated Norris Cotton Cancer Center in Lebanon, N.H. He has co-founded the annual PSI Winterschool on proton therapy in Switzerland and co-chairs the annual ESTRO-Teaching course on protons and ions in Europe. In addition, he presently co-chairs the educational subcommittee of the international Particle Therapy Co-Operative Group (PTCOG) including its annual seminar. Dr. Hug received his medical degree from Ludwig-Maximilians University Medical School in Munich, Germany, graduating summa cum laude. He undertook postgraduate training in Germany and the United States, where he served as chief resident in the Department of Radiation Oncology at Massachusetts General Hospital, Boston.

ProCure Proton Therapy Center

MEET OUR MEDICAL DIRECTORS

CDH Proton Center, A ProCure Center, Chicago, IL

WILLIAM F. HARTSELL, M.D.

William Hartsell, M.D., is the president of Radiation Oncology Consultants (ROC) and the medical director of the CDH Proton Center, A ProCure Center. He previously served as the medical director of radiation oncology at Good Samaritan Cancer Center and Lutheran General Cancer Care Center. Dr. Hartsell joined ROC in 1997 after completing his residency at Rush-Presbyterian St. Lukes Medical Center in Chicago, where he spent six years as an assistant professor and three years as director of the residency program. He also served as an associate professor and clinical director of the radiation oncology program at the University of Tennessee, Memphis. Dr. Hartsell is a board-certified radiation oncologist and specializes in brain tumors, pediatric tumors, head and neck cancers and lung cancer. He earned his medical degree at the University of Oklahoma, Oklahoma City, and completed his internship at Presbyterian-St. Lukes Medical Center in Denver. Dr. Hartsell has authored more than 120 papers on topics including palliative care and the treatment of breast, brain, prostate, and head and neck cancers and Hodgkin disease. He has also directed a number of national studies and participated in more than 70 visiting professorships and guest lecture opportunities. Dr. Hartsell served on the Illinois board of directors for the American Cancer Society for 10 years.

ProCure Proton Therapy Center, Oklahoma City, OK Sameer Keole, M.D., is a partner at Radiation Medicine Associates (RMA) and the medical director at the ProCure Proton Therapy Center, Oklahoma City. Prior to joining RMA and ProCure Proton Therapy Center in Oklahoma, he spent four years treating patients and conducting research at the University of Florida Proton Therapy Institute in Jacksonville, Fla., where he specialized in the treatment of pediatric and prostate patients. While at the University of Florida Proton Therapy Institute, Dr. Keole also served as an assistant professor of medicine at the Shands Cancer Center at the University of Florida at Gainesville. After completing his residency and serving as chief resident at the Wayne State University School of Medicine, Detroit, Dr. Keole joined Academic Radiation Oncologists in Detroit. Dr. Keole completed his undergraduate work at the University of Michigan, Ann Arbor, and received his M.D. from the Ross University School of Medicine, Commonwealth of Dominica, West Indies. He has authored more than 30 papers and abstracts and is sought-after as a presenter at national and international oncology and radiation conferences. Dr. Keole is a member of the American Society for Therapeutic Radiation, the American Medical Association (AMA) and ASTRO (American Society of Therapeutic Radiation Oncology).

SAMEER KEOLE, M.D.

ProCure Proton Therapy Center, Somerset, NJ Brian H. Chon, M.D., is a radiation oncologist with Princeton Radiation Oncology in Princeton, N.J. and the medical director at the ProCure Proton Therapy Center, Somerset, N.J. He graduated with honors from Swarthmore College, Philadelphia and received his medical degree from Robert Wood Johnson Medical School, New Brunswick, N.J. as a member of the esteemed Alpha Omega Alpha Society. His residency was completed at the Massachusetts General Hospital of the Harvard Medical School in Boston where he was appointed chief resident in radiation oncology. Dr. Chon continued at Harvard, advancing his medical career with a fellowship in science research on breast oncogenesis. He gained extensive proton therapy experience from both the Harvard Cyclotron and the Burr Proton Therapy Center at Massachusetts General Hospital with special expertise in cranial and extracranial stereotactic radiation therapy as well as high-dose rate brachytherapy for the treatment of gynecological and breast cancer. In addition, Dr. Chon practices at Princeton Radiation Oncology Center in Monroe TWP, N.J. and currently has medical privileges at Hunterdon Regional Cancer Center in Flemington, N.J., CentraState Medical Center in Freehold, N.J.; St. Mary Medical Center in Langhorne, Pa.; and University Medical Center at Princeton in Princeton, N.J. He is a member of the American Medical Association and the American Society for Therapeutic Radiation Oncology.

BRIAN H. CHON, M.D.

PROCURE TREATMENT CENTERS PARTICIPATING IN CLINICAL TRIAL

For questions about the following trials or about eligibility contact a ProCure Proton Therapy Center research nurse: Oklahoma City, Okla. Heather Perkins 405-773-6728 Warrenville, Ill. Peggy Wellman 630-821-6426 The following trial is currently open to cancer patients through ProCure Proton Therapy Center physician participation.

SUMMARY

The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 treatments over 8-9 weeks) with a higher daily dose of radiation (5 treatments over 1-2 weeks) to see if the effects of the treatments are similar or better

BASIC ELIGIBILITY CRITERIA:

INCLUSION CRITERIA: Histologically confirmed prostate adenocarcinoma Histological evaluation of prostate biopsy with assignment of a Gleason score to the biopsy material PSA values < 10 ng/ml Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.). ECOG performance status 0-1 IPSS score < 16. EXCLUSION CRITERIA: Previous prostate cancer surgery to include: prostatectomy, hyperthermia and cryosurgery Previous pelvic radiation for prostate cancer Androgen deprivation therapy prior to radiation is allowed. However, it is not acceptable if continued during radiation or as adjuvant therapy History of proximal urethral stricture requiring dilatation Current and continuing anticoagulation with warfarin sodium (Coumadin, heparin, low-molecular weight heparin, Clopidogrel bisulfate (Plavix), or equivalent. (Unless it can be stopped to manage treatment related toxicity, to have a biopsy if needed, or for marker placement) Final eligibility for a clinical trial is determined by the health professionals conducting the trial. This information has been obtained from the National Cancer Institute at www.cancer.gov

ProCure is on schedule to open its third (Somerset, N.J.) proton therapy cancer treatment center in early 2012, and its fourth (Seattle) in early 2013. With two currently operating centers in Oklahoma City and Warrenville, Ill., a Chicago suburb ProCure is the only proton therapy treatment organization in the U.S. with multiple treatment centers, allowing wider access to patients, and benefiting from efficiencies and best practices to drive down cost and improve quality care. The ProCure Proton Therapy Center in Somerset, N.J. is on schedule to begin treating patients in early 2012. In Somerset, New Jersey June, the center achieved Substantial Completion and its certificate of occupancy. These designations mean the actual building is complete with just minor follow-up activities required, and that staff may now reside in the building. In addition to center President James Jarrett, some staff is already residing at the center while recruiting efforts are actively underway. A major milestone was achieved on July 14, at which time full beam was extracted from the cyclotron to the degrader, and the beam transport line is now being commissioned. The ProCure Proton Therapy Center in Somerset is collaborating with CentraState Healthcare System and Princeton Radiation Oncology. In Seattle, the SCCA Proton Center, a ProCure center, is in the construction phase and on target to treat patients in early 2013. ProCure has collaborated with the Seattle Cancer Care Association (SCCA), one of only 40 elite National Cancer Institute-designated Comprehensive Cancer Centers in U.S. SCCA and ProCure chose to build the proton center at Northwest Hospital because of the hospitals history of building health care partnerships to provide emerging and innovative treatments to its community, and because the center will be conveniently located near other cancer services and complementary facilities on the hospital campus.

Seattle, Washington

ProCure Proton Therapy Center